TGFB1 and systemic sclerosis: As shown in Fig. 5a, c, there was significantly more accumulation of TGF-β1-positive cells in the dermis layer in the SSc mice than in the normal mice (P < 0.001), but this accumulation was evidently reduced in the EV-treated group to a level similar to that in the normal group (P < 0.001).